Extracellular vesicles and microRNAs in cancer progression.

Advances in clinical chemistry Pub Date : 2025-01-01 Epub Date: 2025-01-28 DOI:10.1016/bs.acc.2024.11.004
Nicola S Orefice, Gianluca Petrillo, Claudia Pignataro, Martina Mascolo, Giada De Luca, Sara Verde, Francesca Pentimalli, Gerolama Condorelli, Cristina Quintavalle
{"title":"Extracellular vesicles and microRNAs in cancer progression.","authors":"Nicola S Orefice, Gianluca Petrillo, Claudia Pignataro, Martina Mascolo, Giada De Luca, Sara Verde, Francesca Pentimalli, Gerolama Condorelli, Cristina Quintavalle","doi":"10.1016/bs.acc.2024.11.004","DOIUrl":null,"url":null,"abstract":"<p><p>Extracellular vesicles (EVs) have emerged as critical mediators of intercellular communication in cancer. These membranous structures, secreted by normal and cancerous cells, carry a cargo of bioactive molecules including microRNAs (miRNAs) that modulate various cellular processes. miRNAs are small non-coding RNAs that play pivotal roles in post-transcriptional gene regulation and have been implicated in cancer initiation, progression, and metastasis. In cancer, tumor-derived EVs transport specific miRNAs to recipient cells, modulating tumorigenesis, growth, angiogenesis, and metastasis. Dysregulation of miRNA expression profiles within EVs contributes to the acquisition of cancer hallmarks that include increased proliferation, survival, and migration. EV miRNAs influence the tumor microenvironment, promoting immune evasion, remodeling the extracellular matrix, and establishing pre-metastatic niches. Understanding the complex interplay between EVs, miRNAs, and cancer holds significant promise for developing novel diagnostic and therapeutic strategies. This chapter provides insights into the role of EV-mediated miRNA signaling in cancer pathogenesis, highlighting its potential as a biomarker for cancer detection, prognosis, and treatment response assessment.</p>","PeriodicalId":101297,"journal":{"name":"Advances in clinical chemistry","volume":"125 ","pages":"23-54"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in clinical chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/bs.acc.2024.11.004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/28 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Extracellular vesicles (EVs) have emerged as critical mediators of intercellular communication in cancer. These membranous structures, secreted by normal and cancerous cells, carry a cargo of bioactive molecules including microRNAs (miRNAs) that modulate various cellular processes. miRNAs are small non-coding RNAs that play pivotal roles in post-transcriptional gene regulation and have been implicated in cancer initiation, progression, and metastasis. In cancer, tumor-derived EVs transport specific miRNAs to recipient cells, modulating tumorigenesis, growth, angiogenesis, and metastasis. Dysregulation of miRNA expression profiles within EVs contributes to the acquisition of cancer hallmarks that include increased proliferation, survival, and migration. EV miRNAs influence the tumor microenvironment, promoting immune evasion, remodeling the extracellular matrix, and establishing pre-metastatic niches. Understanding the complex interplay between EVs, miRNAs, and cancer holds significant promise for developing novel diagnostic and therapeutic strategies. This chapter provides insights into the role of EV-mediated miRNA signaling in cancer pathogenesis, highlighting its potential as a biomarker for cancer detection, prognosis, and treatment response assessment.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
细胞外囊泡和microrna在癌症进展中的作用。
细胞外囊泡(EVs)已成为癌症细胞间通讯的重要介质。这些由正常细胞和癌细胞分泌的膜状结构携带大量生物活性分子,包括调节各种细胞过程的microrna (mirna)。mirna是一种小的非编码rna,在转录后基因调控中起关键作用,并与癌症的发生、进展和转移有关。在癌症中,肿瘤源性ev将特定的mirna转运到受体细胞,调节肿瘤的发生、生长、血管生成和转移。ev内miRNA表达谱的失调有助于获得包括增殖、存活和迁移增加在内的癌症特征。EV mirna影响肿瘤微环境,促进免疫逃避,重塑细胞外基质,建立转移前生态位。了解ev、mirna和癌症之间复杂的相互作用对开发新的诊断和治疗策略具有重要意义。本章深入探讨了ev介导的miRNA信号在癌症发病机制中的作用,强调了其作为癌症检测、预后和治疗反应评估的生物标志物的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Endocrine disruption in metabolic disorders: Biomarkers and therapeutic targets. Autophagy in lipid metabolism. Preface. Oncogenesis in cholangiocarcinoma. Advances in miRNA detection.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1